Resources
- Comprehensive Care
- Follow-Up Assessment
- Pain Assessment
- Patient Selection and Opioid Treatment Agreements
- Risk Stratification
- Disease Management
- Acute Pain
- Back Pain
- Breakthrough Pain
- Cancer Pain
- Carpal Tunnel Syndrome
- Chronic Noncancer Pain
- Complex Regional Pain Syndrome
- Fibromyalgia
- Headache
- Neuropathic Pain
- Osteoarthritis
- Pharmacotherapy
- NSAIDs
- Older Patients
- Opioid Prescribing
Featured Resource

Best Practices in Fibromyalgia Diagnosis and Multimodal Management: Insights...
Consensus Delphi Statements
Journals
Select your area of interest:
PubMed Search
Enter search terms here.







The Drug Abuse Screening Test (DAST) was developed in 1982 and is still an excellent screening tool. It is a 28-item self-report scale that consists of items that parallel those of the Michigan Alcoholism Screening Test (MAST). The DAST has “exhibited valid psychometric properties” and has been found to be “a sensitive screening instrument for the abuse of drugs other than alcohol.
A five-question clinical interview or patient questionnaire to help stratify patients based on the risk for opioid-related misuse and abuse.
Convenient list of aberrant drug-related behaviors more or less predictive of an addiction disorder